Every year, thousands of Ghanaian women confront a disease whose cost extends far beyond the hospital ward. Breast cancer takes lives, drains household incomes, disrupts careers and places an additional burden on families that must often combine treatment with work, childcare and other responsibilities.
For Ghana, the growing burden is increasingly becoming an economic concern because many of the women affected are within the country’s productive age group.
The Ghana Health Service estimates that Ghana records about 4,650 new breast cancer cases and approximately 2,060 deaths annually. The figures were disclosed by Deputy Minister of Health Dr Grace Ayensu-Danquah at the launch of the 2026 National Pink Month, held on September 30 under the theme “Early Action, Better Outcomes.”
A separate disclosure at the same launch by Dr Mary-Ann Dadzie, a radiation oncologist at Korle-Bu Teaching Hospital, put the annual burden at more than 5,000 cases and 2,695 deaths. She said about 70 percent of patients report to health facilities with advanced disease, making treatment more difficult and reducing their chances of survival.
The difference between the estimates underscores the need for stronger cancer surveillance and consistent national data. The broader message, however, remains clear: Ghana is losing a significant number of women to a disease for which outcomes can improve substantially when it is detected and treated early.
The economic consequences are already visible.
At a Breast Society of Ghana stakeholders forum in August 2026, its President, Prof. Josephine Nsaful, said between 60 and 80 percent of breast cancer cases were still diagnosed at an advanced stage. She cited a 2020 study of 217 patients at three cancer centres which found the average total cost of treatment at GH¢34,631 per patient. The figure included direct medical expenses, non-medical costs and approximately GH¢13,000 in indirect costs, including income lost by patients and caregivers.
The most striking figure is the distribution of those economic losses. Prof. Nsaful said 89 percent occurred among women aged between 20 and 59, a group that constitutes a significant part of the country’s productive workforce. She therefore argued that breast cancer should not be considered only a health issue because of its consequences for productivity and the national economy.
When a working woman becomes seriously ill, the economic effect can begin long before death. Treatment may require repeated hospital visits, surgery, chemotherapy or radiotherapy. Income can fall when the patient takes time away from work. Employers may lose experienced workers, while families may lose the earnings of caregivers who have to accompany relatives to hospitals or provide care at home.
For households already operating on tight budgets, the shock can be severe. Treatment costs can compete with school fees, rent, food and other basic expenses. Long-term illness can also force families to sell assets or borrow money, weakening their financial resilience long after treatment has ended.
Late presentation is one of the major factors deepening the problem. At the 2026 national launch, Dr Dadzie said fear, stigma, financial difficulties and long distances to health facilities contributed to delays. She advised women to seek medical help within two weeks of noticing unusual changes rather than waiting for months or years. “Seek medical help within two weeks, not three years,” she said.
The Ghana Health Service is now seeking to move detection closer to communities. In 2026, it received ultrasound machines and medical supplies for selected district hospitals, while a new mobile mammogram initiative is being developed to reach communities with screening and diagnostic services. The Service says three mobile mammogram vans are expected to be operational by the end of the year.
Access, however, must go beyond screening. A woman who receives an abnormal result needs affordable diagnostic tests, a functioning referral system and timely treatment. Without that chain, early detection can become an incomplete victory.
The First Lady, Lordina Dramani Mahama, recently made the case for treating breast cancer care as a right rather than a privilege, saying, “Breast cancer screening and treatment are your rights as a Ghanaian woman, period.” She also warned that the success of government interventions should be measured “not in policies written, but in women who are treated and in lives that are saved in futures that are preserved.”
For Ghana, the argument for early action is therefore larger than saving individual lives. It is about preserving workers, protecting household incomes, reducing avoidable healthcare costs and keeping experienced women economically active.
Pink October may last a month. The economic cost of delayed action lasts much longer.
